V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001054 | 240011723 | null | null | Curative (C) | null | 2018-04-07 | null | null | null | TRIAL UNSPECIFIED | 101319744 |
| 240001091 | 240011724 | null | 69 | null | null | 2020-08-06 | null | 02 | null | HYDROXYCARBAMIDE | 100020934 |
| 240001105 | 240011726 | 1.8 | 78.6 | 03 | null | 2021-08-29 | null | null | N | AML19 TRIAL | 100233112 |
| 240001153 | 240011727 | 1.59 | 89.8 | null | 2020-10-17 | 2021-01-12 | Rituximab | 02 | null | RITUXIMAB | 100890892 |
| 240001201 | 240011729 | 1.83 | 85 | Curative (C) | null | 2021-01-03 | null | N | N | BENDAMUSTINE + RITUXIMAB | 101635703 |
| 240001301 | 240011731 | 1.64 | 101 | Curative (C) | null | 2021-07-18 | null | 02 | N | AZACITIDINE | 101465330 |
| 240001372 | 240011734 | 1.72 | 79 | null | null | 2019-06-23 | Rituximab | 02 | null | RITUXIMAB | 100692052 |
| 240001607 | 240011737 | 1.79 | 92.35 | 03 | 2022-04-24 | 2022-04-26 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 101050569 |
| 240001749 | 240011738 | 1.49 | 106.9 | null | null | 2022-04-15 | null | null | null | TRIAL UNSPECIFIED | 101345435 |
| 240001809 | 240011739 | 1.8 | 0 | null | 2022-05-07 | 2022-05-12 | CHOP R + METHOTREXATE | 01 | N | RUXOLITINIB | 100465468 |
| 240001816 | 240011740 | 1.66 | 12.06 | null | null | 2020-09-12 | CYTARABINE + FLUDARABINE | N | null | MELPHALAN | 101132644 |
| 240001877 | 240011741 | 1.69 | 61.1 | null | null | 2019-10-21 | null | null | null | BUSULFAN | 100172582 |
| 240001892 | 240011743 | 1.68 | 82 | Curative (C) | 2020-10-04 | 2020-10-05 | Vinblastine | N | N | IBRUTINIB | 100899672 |
| 240001895 | 240011744 | 1.5 | 57.9 | 03 | null | null | Methotrexate intrathecal | 02 | N | CLADRIBINE | 100246995 |
| 240001922 | 240011745 | 1.75 | 98 | Palliative (P) | null | 2020-04-09 | null | null | N | PEG INTERFERON | 101630483 |
| 240001939 | 240011746 | 1.72 | 106.85 | 03 | null | 2022-04-27 | Cytarabine High Dose | 02 | N | CNS LOW GRADE GLIOMA VINBLASTINE | 100741940 |
| 240002063 | 240011750 | 1.83 | 106.5 | Curative (C) | 2018-11-01 | 2018-12-18 | null | Y | null | METHOTREXATE INTRATHECAL | 100752132 |
| 240002093 | 240011751 | 1.64 | 59.25 | Palliative (P) | 2017-09-12 | 2018-01-23 | CYCLOPHOSPHAMIDE + FLUDARABINE | Y | N | INTERFERON ALFA | 100488667 |
| 240002109 | 240011752 | 1.58 | 128.6 | null | null | 2019-07-28 | null | Y | null | VENETOCLAX | 100399769 |
| 240002224 | 240011754 | 1.8 | 57.7 | Curative (C) | 2021-03-19 | 2021-08-07 | Bortezomib + Thalidomide +/- Dex | N | N | ALCL ALCL 99 CLOSED AM 1, 2 OR 3 | 100606828 |
| 240002248 | 240011756 | 1.65 | 105.3 | null | 2017-12-05 | 2017-12-05 | Bortezomib (weekly) | 01 | null | CISPLATIN + GEMCITABINE | 100581147 |
| 240002282 | 240011757 | 0 | null | Curative (C) | null | 2019-12-07 | GDP | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101256721 |
| 240002287 | 240011758 | 1.58 | 58.8 | Adjuvant (A) | 2018-07-21 | 2018-07-26 | null | 02 | N | ALL UKALL2011 IND B | 101567333 |
| 240002351 | 240011759 | 1.76 | 63.4 | Curative (C) | 2018-03-27 | 2018-05-31 | null | 02 | null | BUSULFAN | 100578083 |
| 240002374 | 240011760 | null | 120 | Curative (C) | null | 2020-09-21 | null | 01 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100187681 |
| 240002391 | 240011761 | 0 | 0 | null | 2021-05-19 | 2021-06-26 | LENALIDOMIDE | 01 | null | AML MYECHILD 01 HD ARAC | 101179262 |
| 240002478 | 240011763 | 1.83 | 96.25 | Curative (C) | 2022-02-03 | 2022-02-10 | null | 02 | N | CVP R | 100059700 |
| 240002489 | 240011765 | 1.53 | 69 | Curative (C) | 2021-10-14 | 2021-10-16 | IPILIMUMAB + NIVOLUMAB | 02 | N | IBRUTINIB | 101869442 |
| 240002577 | 240011766 | 1.75 | 86.7 | Palliative (P) | null | 2021-09-05 | Sorafenib | null | N | VENETOCLAX | 101309020 |
| 240002610 | 240011767 | 1.54 | 82.1 | null | 2020-01-07 | 2020-01-16 | GEMTUZUMAB OZOGAMICIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100238819 |
| 240002631 | 240011769 | 1.61 | 70.8 | null | 2019-06-27 | 2019-09-04 | Midostaurin | 02 | null | QUIZARTINIB | 100610839 |
| 240002691 | 240011771 | 1.82 | null | null | 2022-02-02 | 2022-02-09 | null | 02 | N | ANAGRELIDE | 101090800 |
| 240002722 | 240011773 | 1.67 | 60 | Curative (C) | null | 2018-07-27 | PEG INTERFERON | null | null | ALL UKALL2011 STD BFM CONS B | 100415407 |
| 240002786 | 240011775 | 1.68 | 77.6 | null | 2018-09-26 | 2018-10-02 | FCR Oral - Cycle 1 | 02 | null | PEMBROLIZUMAB | 100601343 |
| 240002845 | 240011777 | 1.65 | 87.3 | Curative (C) | 2020-03-20 | 2020-06-14 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101713235 |
| 240000626 | 240011780 | 0 | 34.9 | null | 2017-10-31 | 2017-11-16 | R Chlorambucil | Y | null | AML MYECHILD 01 HD ARAC | 101019381 |
| 240000908 | 240011820 | null | null | null | null | 2018-08-12 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101326969 |
| 240000920 | 240011825 | null | null | null | 2022-03-08 | 2022-03-10 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100931630 |
| 240000921 | 240011826 | 0 | 71.5 | Palliative (P) | 2021-10-03 | 2021-10-04 | Methotrexate + Folinic acid | 1 | null | METHOTREXATE | 100958443 |
| 240000922 | 240011827 | null | null | null | null | null | null | 02 | null | METHOTREXATE | 100060122 |
| 240000927 | 240011828 | 1.67 | 66 | null | 2019-08-14 | 2019-08-30 | Rituximab | 01 | null | RITUXIMAB | 100713957 |
| 240000931 | 240011829 | 1.78 | 23.6 | null | null | 2022-03-23 | null | N | null | TRIAL UNSPECIFIED | 100881006 |
| 240000948 | 240011832 | 1.68 | 70 | null | 2020-08-28 | 2020-11-22 | Rituximab | 02 | null | RITUXIMAB | 101636865 |
| 240000988 | 240011835 | 1.59 | 59.1 | null | 2020-05-22 | 2020-05-22 | Hydroxycarbamide | N | null | HYDROXYCARBAMIDE | 100098412 |
| 240001054 | 240011838 | 1.68 | 78.6 | null | null | 2018-05-07 | null | 02 | null | CHOP R | 101319744 |
| 240001095 | 240011840 | null | null | null | null | 2021-01-06 | null | null | null | TRIAL UNSPECIFIED | 101404275 |
| 240001153 | 240011842 | null | null | null | null | 2021-01-26 | null | 02 | null | HYDROXYCARBAMIDE | 100890892 |
| 240001607 | 240011843 | 1.62 | 73.5 | null | null | 2022-05-29 | null | null | null | METHOTREXATE | 101050569 |
| 240001749 | 240011844 | 1.7 | 65.9 | Curative (C) | null | 2022-05-21 | null | null | N | AZACITIDINE | 101345435 |
| 240001895 | 240011847 | 1.62 | 23.1 | 03 | null | null | null | null | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100246995 |